Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Correlate - Safety and Effectiveness of Regorafenib in Routine Clinical Practice Settings

NCT02042144 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT02042144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02042144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Correlate - Safety and Effectiveness of Regorafenib in Routine Clinical Practice Settings
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
April 8, 2014
Completion date
November 10, 2017
Enrollment
1,034 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasms